StockNews.com initiated coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a report issued on Saturday. The firm issued a hold rating on the stock. Several other equities research analysts also recently commented on the stock. TheStreet upgraded shares of MEI Pharma from a d- rating to a c- rating in a research […]